These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8311280)

  • 1. Spinal and cortical evoked potential studies in the ketamine-anesthetized rabbit: fentanyl exerts component-specific, naloxone-reversible changes dependent on stimulus intensity.
    Lee VC
    Anesth Analg; 1994 Feb; 78(2):280-6. PubMed ID: 8311280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of high-dose opioid anesthesia on posterior tibial nerve somatosensory cortical evoked potentials: effects of fentanyl, sufentanil, and alfentanil.
    Kalkman CJ; Leyssius AT; Bovill JG
    J Cardiothorac Anesth; 1988 Dec; 2(6):758-64. PubMed ID: 17171885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fentanyl and naloxone on human somatic and auditory-evoked potential components.
    Velasco M; Velasco F; Castañeda R; Sánchez R
    Neuropharmacology; 1984 Mar; 23(3):359-66. PubMed ID: 6728127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of ketamine-midazolam with those of fentanyl-midazolam on cortical somatosensory evoked potentials during major spine surgery.
    Langeron O; Lille F; Zerhouni O; Orliaguet G; Saillant G; Riou B; Coriat P
    Br J Anaesth; 1997 Jun; 78(6):701-6. PubMed ID: 9215023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of naloxone and repeated stimulus presentation on cortical somatosensory evoked potential (SEP) amplitude in the rat.
    Dowman R; Rosenfeld JP
    Exp Neurol; 1985 Jul; 89(1):9-23. PubMed ID: 4007118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response suppression of noxiously evoked activity of WDR neurons by spinally administered fentanyl.
    Suzukawa M; Matsumoto M; Collins JG; Kitahata LM; Yuge O
    Anesthesiology; 1983 Jun; 58(6):510-3. PubMed ID: 6859581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous anesthetic alterations on the spinal-sciatic evoked response in swine.
    Mongan PD; Peterson RE
    Anesth Analg; 1993 Jul; 77(1):149-54. PubMed ID: 8317723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal cord pathways mediating somatosensory evoked potentials.
    Powers SK; Bolger CA; Edwards MS
    J Neurosurg; 1982 Oct; 57(4):472-82. PubMed ID: 7108596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of high-dose fentanyl on human median nerve somatosensory-evoked responses.
    Schubert A; Drummond JC; Peterson DO; Saidman LJ
    Can J Anaesth; 1987 Jan; 34(1):35-40. PubMed ID: 3829283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between primary somatosensory cortex- and vertex-derived somatosensory-evoked potentials in the rat.
    Stienen PJ; van den Brom WE; de Groot HN; Venker-van Haagen AJ; Hellebrekers LJ
    Brain Res; 2004 Dec; 1030(2):256-66. PubMed ID: 15571674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of desflurane on spinal somatosensory-evoked potentials and conductive spinal cord evoked potential.
    Jou IM; Chern TC; Chen TY; Tsai YC
    Spine (Phila Pa 1976); 2003 Aug; 28(16):1845-50. PubMed ID: 12923473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose of S+-ketamine prevents long-term potentiation in pain pathways under strong opioid analgesia in the rat spinal cord in vivo.
    Benrath J; Brechtel C; Stark J; Sandkühler J
    Br J Anaesth; 2005 Oct; 95(4):518-23. PubMed ID: 16113037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic efficacy of low-dose ketamine. Somatosensory-evoked responses in relation to subjective pain ratings.
    Kochs E; Scharein E; Möllenberg O; Bromm B; Schulte am Esch J
    Anesthesiology; 1996 Aug; 85(2):304-14. PubMed ID: 8712446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fentanyl suppression of nociceptive neurons in the superficial dorsal horn of the cat.
    Kumeta Y; Murata K; Kitahata LM; Aoki M; Nishio Y; Collins JG
    Anesthesiology; 1988 Sep; 69(3):371-6. PubMed ID: 3415016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fentanyl and morphine on intraoperative somatosensory cortical-evoked potentials.
    Pathak KS; Brown RH; Cascorbi HF; Nash CL
    Anesth Analg; 1984 Sep; 63(9):833-7. PubMed ID: 6465579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Operant conditioning of somatosensory evoked potential (SEP) amplitude in rats. I. Specific changes in SEP amplitude and a naloxone-reversible somatotopically specific change in facial nociception.
    Dowman R; Rosenfeld JP
    Brain Res; 1985 May; 333(2):201-12. PubMed ID: 3995293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-latency component of cerebral evoked potentials in anesthetized cats.
    Lee KH; Kim J; Chung JM
    J Neurosurg; 1986 Sep; 65(3):392-7. PubMed ID: 3734889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S(+)-ketamine attenuates myogenic motor-evoked potentials at or distal to the spinal alpha-motoneuron.
    Scheufler KM; Thees C; Nadstawek J; Zentner J
    Anesth Analg; 2003 Jan; 96(1):238-44, table of contents. PubMed ID: 12505959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation by ketamine of fentanyl antinociception. I. An experimental study in rats showing that ketamine administered by non-spinal routes targets spinal cord antinociceptive systems.
    Nadeson R; Tucker A; Bajunaki E; Goodchild CS
    Br J Anaesth; 2002 May; 88(5):685-91. PubMed ID: 12067007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ketamine on human somatosensory evoked potentials and its modification by nitrous oxide.
    Schubert A; Licina MG; Lineberry PJ
    Anesthesiology; 1990 Jan; 72(1):33-9. PubMed ID: 2297131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.